Search

everythinglearnresearchcommunity

for

Search:↓

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

PCOS is caused by both genetics and environmental factors like diet and obesity.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Hirsutism is when women have too much hair growth, often due to a bit more androgen hormones and sensitive skin.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.